NYSE American: VENU

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Electro Optic Systems (ASX: EOS) lifts FY26 guidance as order book hits A$846m

Verizon (NYSE: VZ) jumps 6% as AI fiber widens the turnaround story

Lindian Resources (ASX: LIN) jumps 17% as Kangankunde nears first production

Booz Allen Hamilton (NYSE: BAH) jumps 10% as defense backlog strengthens

Venu Holding reports asset surge and FireSuite momentum in Q3 2025, but market reaction stays cautious

Venu Holding Corporation stock slides 14% despite strong Q3 asset growth and artist partnerships. Find out how its multi-venue strategy is shaping investor views.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

November 15, 2025